Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Articles
Oncology

European Heart Journal – Cardio-Oncology

Cardiovascular toxicity of BTK inhibitors: comparing what can be compared

14 October 2026Original research1 min read

By Annamaria Brioli.

Read the original

On this page

Abstract
Keywords
Authors
Source

Abstract

Annamaria Brioli; Cardiovascular toxicity of BTK inhibitors: comparing what can be compared, European Heart Journal – Cardio-Oncology, , aabag012, https://

Keywords

Chronic Lymphocytic Leukemia Research
Open access

Authors

Annamaria Brioli

Source

Published in European Heart Journal – Cardio-Oncology. The abstract is shown as published and remains the work of its authors; read the full article at the source.

doi.org/10.1093/ehjco/aabag012

Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.

At a glance

Journal: European Heart Journal – Cardio-Oncology
Type: Original research
Published: 14 October 2026
Specialty: Oncology

More in oncology

The value of breast brachytherapy boost in the current era: a narrative literature review from the GEC-ESTRO breast cancer working groupClinical and Translational Radiation Oncology · 2026Added todayNew
Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European UnionThe Lancet Regional Health. Europe · 2026Added todayNew

Read around a topic while you study.

Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.

Read time

1 min

Authors

1

DOI

10.1093/ehjco/aabag012

Evaluation of the impact of virtual reality as a non-pharmacological intervention for pain and anxiety during hematology procedures and chemotherapy: a controlled trialFuture Science OA · 2026Added todayNew

Therapeutic potential of ayurvedic herbal drugs for arbuda (cancer): An integrative conceptual analysisWorld Journal of Pharmaceutical Research · 2026Added todayNew

Impact of TERT and CDKN2A/B driver mutations on meningioma recurrence: a systematic review and meta-analysisZhurnal voprosy neirokhirurgii imeni N. N. Burdenko · 2026Added todayNew

Randomized controlled trials of radiation therapy for cutaneous malignancies: a systematic reviewClinical and Translational Radiation Oncology · 2026Added todayNew

Safety Profiles of Immune Checkpoint Inhibitor Strategies in Gastrointestinal Cancers and Their Association With Clinical Outcomes: A Systematic Review and Meta-AnalysisCancer medicine · 2026Added todayNew

Graph attention network-driven single-cell omics analysis reveals how B4GALNT1-mediated glycosylation remodelling of the ferroptosis-pyroptosis network promotes drug resistance in hepatocellular carcinomaClinical and translational medicine · 2026Added todayNew

A Meta-Analysis on Outcomes of Zanidatamab Plus Chemotherapy in Patients with Advanced HER2-positive Gastroesophageal AdenocarcinomaJournal of gastrointestinal cancer · 2026Added todayNew

Stage-driven mortality and clinical risk stratification among lung cancer patients in Dhaka, Bangladesh: A multi-hospital secondary analysisPloS one · 2026Added todayNew

A Remotely Delivered Exercise-Based Rehabilitation Program for Patients with Persistent Chemotherapy-Induced Peripheral Neuropathy (EX-CIPN): A Phase I Feasibility TrialCurrent Oncology · 2026Added todayNew

Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-ChemotherapyCancer medicine · 2026Added todayNew